What is the next step if a morning cortisol test is highly suggestive of Cushing's (Cushing's syndrome)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Next Steps After Morning Cortisol Test Suggestive of Cushing's Syndrome

The next step after a morning cortisol test suggestive of Cushing's syndrome is to confirm hypercortisolism with additional screening tests, specifically 24-hour urinary free cortisol (UFC), late-night salivary cortisol (LNSC), and low-dose dexamethasone suppression test (LDDST), followed by determination of ACTH status. 1

Confirming Hypercortisolism

A single morning cortisol test alone is insufficient for diagnosis. You must first confirm the presence of hypercortisolism using established algorithms:

  1. 24-hour Urinary Free Cortisol (UFC):

    • Collect for 3 consecutive days
    • Diagnostic cutoff: >193 nmol/24h (>70 μg/m²)
    • Sensitivity: 89%, Specificity: 100% 1
    • Ensure complete collections with appropriate total volumes
  2. Late-Night Salivary Cortisol (LNSC):

    • Collect at bedtime
    • Based on local assay cutoff
    • Sensitivity: 95%, Specificity: 100% 1
    • Particularly useful for detecting cyclic Cushing's syndrome 1, 2
  3. Low-Dose Dexamethasone Suppression Test (LDDST):

    • 0.5 mg every 6 hours for 48 hours (or overnight 1-mg test)
    • Diagnostic cutoff: ≥50 nmol/l (≥1.8 μg/dl)
    • Sensitivity: 95%, Specificity: 80% 1
    • Consider measuring dexamethasone levels to ensure adequate absorption 1

Determining ACTH Status

After confirming hypercortisolism, determine if it's ACTH-dependent or independent:

  • Measure morning plasma ACTH (09:00h):
    • ACTH detectable (>5 ng/l or >1.1 pmol/l): ACTH-dependent Cushing's syndrome
    • ACTH low or undetectable: ACTH-independent Cushing's syndrome 1

Further Evaluation Based on ACTH Status

If ACTH-Dependent:

  1. Pituitary MRI with contrast:

    • Sensitivity for adenoma detection: 63%, Specificity: 92% 1
  2. CRH Stimulation Test:

    • 1.0 μg/kg CRH intravenously
    • Diagnostic cutoff: ≥20% increase in cortisol
    • Sensitivity: 74-100% 1
  3. If MRI negative or equivocal:

    • Bilateral inferior petrosal sinus sampling (BSIPSS) with CRH or desmopressin
    • Central-to-peripheral ACTH ratio ≥3 confirms pituitary source
    • Must be performed at specialized centers by experienced interventional radiologists 1

If ACTH-Independent:

  • Adrenal CT or MRI to identify adrenal adenoma, carcinoma, or bilateral hyperplasia 1

Important Considerations

  • False positives/negatives: Be aware of factors that can interfere with test results:

    • Medications affecting CYP3A4 (phenobarbital, carbamazepine, fluoxetine)
    • Altered corticosteroid binding globulin levels (oral estrogens, pregnancy)
    • Renal impairment (affects UFC) 1
  • Cyclic Cushing's syndrome: Consider multiple, sequential measurements if cortisol production fluctuates 2

  • Children vs. adults: In prepubertal children, growth failure combined with weight gain is highly specific for Cushing's syndrome. Post-pubertal adolescents should be evaluated using adult criteria 1, 2

  • Test quality: Mass spectrometry methods are preferred over immunoassays for better sensitivity in cortisol measurements 2

Remember that early diagnosis and treatment are crucial for reducing morbidity and mortality associated with Cushing's syndrome, including cardiovascular complications, infections, and neuropsychiatric disorders 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cyclic Cushing's Syndrome Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cushing syndrome.

Nature reviews. Disease primers, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.